2019 Q1 Form 10-Q Financial Statement
#000156459019016480 Filed on May 07, 2019
Income Statement
| Concept | 2019 Q1 | 2018 Q1 |
|---|---|---|
| Revenue | $0.00 | $0.00 |
| YoY Change | ||
| Cost Of Revenue | ||
| YoY Change | ||
| Gross Profit | ||
| YoY Change | ||
| Gross Profit Margin | ||
| Selling, General & Admin | $13.06M | $2.600M |
| YoY Change | 402.31% | |
| % of Gross Profit | ||
| Research & Development | $23.40M | $0.00 |
| YoY Change | ||
| % of Gross Profit | ||
| Depreciation & Amortization | $544.0K | $0.00 |
| YoY Change | ||
| % of Gross Profit | ||
| Operating Expenses | $36.46M | $2.597M |
| YoY Change | 1303.97% | |
| Operating Profit | -$36.46M | -$2.597M |
| YoY Change | 1303.97% | |
| Interest Expense | $4.830M | $0.00 |
| YoY Change | ||
| % of Operating Profit | ||
| Other Income/Expense, Net | $4.825M | |
| YoY Change | ||
| Pretax Income | -$31.64M | -$2.600M |
| YoY Change | 1116.77% | |
| Income Tax | -$100.0K | $0.00 |
| % Of Pretax Income | ||
| Net Earnings | -$31.59M | -$2.597M |
| YoY Change | 1116.25% | |
| Net Earnings / Revenue | ||
| Basic Earnings Per Share | ||
| Diluted Earnings Per Share | -$324.6K | -$99.05K |
| COMMON SHARES | ||
| Basic Shares Outstanding | 121.5M | |
| Diluted Shares Outstanding |
Balance Sheet
| Concept | 2019 Q1 | 2018 Q1 |
|---|---|---|
| SHORT-TERM ASSETS | ||
| Cash & Short-Term Investments | $470.4M | |
| YoY Change | ||
| Cash & Equivalents | $97.05M | $5.000K |
| Short-Term Investments | $373.4M | |
| Other Short-Term Assets | $10.50M | |
| YoY Change | ||
| Inventory | ||
| Prepaid Expenses | ||
| Receivables | ||
| Other Receivables | ||
| Total Short-Term Assets | $476.6M | |
| YoY Change | ||
| LONG-TERM ASSETS | ||
| Property, Plant & Equipment | $20.43M | |
| YoY Change | ||
| Goodwill | ||
| YoY Change | ||
| Intangibles | $603.0K | |
| YoY Change | ||
| Long-Term Investments | $214.6M | |
| YoY Change | ||
| Other Assets | $432.0K | |
| YoY Change | ||
| Total Long-Term Assets | $272.7M | |
| YoY Change | ||
| TOTAL ASSETS | ||
| Total Short-Term Assets | $476.6M | |
| Total Long-Term Assets | $272.7M | |
| Total Assets | $749.4M | |
| YoY Change | ||
| SHORT-TERM LIABILITIES | ||
| YoY Change | ||
| Accounts Payable | $12.98M | |
| YoY Change | ||
| Accrued Expenses | $14.30M | |
| YoY Change | ||
| Deferred Revenue | ||
| YoY Change | ||
| Short-Term Debt | $0.00 | |
| YoY Change | ||
| Long-Term Debt Due | ||
| YoY Change | ||
| Total Short-Term Liabilities | $27.27M | |
| YoY Change | ||
| LONG-TERM LIABILITIES | ||
| Long-Term Debt | $0.00 | |
| YoY Change | ||
| Other Long-Term Liabilities | $6.065M | |
| YoY Change | ||
| Total Long-Term Liabilities | $6.065M | |
| YoY Change | ||
| TOTAL LIABILITIES | ||
| Total Short-Term Liabilities | $27.27M | |
| Total Long-Term Liabilities | $6.065M | |
| Total Liabilities | $68.14M | |
| YoY Change | ||
| SHAREHOLDERS EQUITY | ||
| Retained Earnings | -$243.1M | |
| YoY Change | ||
| Common Stock | $922.9M | |
| YoY Change | ||
| Preferred Stock | ||
| YoY Change | ||
| Treasury Stock (at cost) | ||
| YoY Change | ||
| Treasury Stock Shares | ||
| Shareholders Equity | $681.2M | -$2.594M |
| YoY Change | ||
| Total Liabilities & Shareholders Equity | $749.4M | |
| YoY Change |
Cashflow Statement
| Concept | 2019 Q1 | 2018 Q1 |
|---|---|---|
| OPERATING ACTIVITIES | ||
| Net Income | -$31.59M | -$2.597M |
| YoY Change | 1116.25% | |
| Depreciation, Depletion And Amortization | $544.0K | $0.00 |
| YoY Change | ||
| Cash From Operating Activities | -$30.26M | $5.000K |
| YoY Change | -605220.0% | |
| INVESTING ACTIVITIES | ||
| Capital Expenditures | $10.42M | $0.00 |
| YoY Change | ||
| Acquisitions | ||
| YoY Change | ||
| Other Investing Activities | $43.31M | $0.00 |
| YoY Change | ||
| Cash From Investing Activities | $32.89M | $0.00 |
| YoY Change | ||
| FINANCING ACTIVITIES | ||
| Cash Dividend Paid | ||
| YoY Change | ||
| Common Stock Issuance & Retirement, Net | $0.00 | |
| YoY Change | ||
| Debt Paid & Issued, Net | ||
| YoY Change | ||
| Cash From Financing Activities | $684.0K | 0.000 |
| YoY Change | ||
| NET CHANGE | ||
| Cash From Operating Activities | -$30.26M | 5.000K |
| Cash From Investing Activities | $32.89M | 0.000 |
| Cash From Financing Activities | $684.0K | 0.000 |
| Net Change In Cash | $3.316M | 5.000K |
| YoY Change | 66220.0% | |
| FREE CASH FLOW | ||
| Cash From Operating Activities | -$30.26M | $5.000K |
| Capital Expenditures | $10.42M | $0.00 |
| Free Cash Flow | -$40.68M | $5.000K |
| YoY Change | -813680.0% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2019Q1 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
12976000 | |
| CY2018Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
12338000 | |
| CY2019Q1 | allo |
Accrued And Other Liabilities Current
AccruedAndOtherLiabilitiesCurrent
|
14289000 | |
| CY2018Q4 | allo |
Accrued And Other Liabilities Current
AccruedAndOtherLiabilitiesCurrent
|
17121000 | |
| CY2018Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
92432000 | |
| CY2019Q1 | us-gaap |
Short Term Investments
ShortTermInvestments
|
373392000 | |
| CY2018Q4 | us-gaap |
Short Term Investments
ShortTermInvestments
|
366952000 | |
| CY2019Q1 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
10487000 | |
| CY2018Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
8598000 | |
| CY2019Q1 | us-gaap |
Assets Current
AssetsCurrent
|
476627000 | |
| CY2018Q4 | us-gaap |
Assets Current
AssetsCurrent
|
467982000 | |
| CY2019Q1 | us-gaap |
Long Term Investments
LongTermInvestments
|
214588000 | |
| CY2018Q4 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
33015000 | |
| CY2019Q1 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
20426000 | |
| CY2018Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
8595000 | |
| CY2019Q1 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
603000 | |
| CY2018Q4 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
754000 | |
| CY2019Q1 | us-gaap |
Restricted Cash Noncurrent
RestrictedCashNoncurrent
|
4299000 | |
| CY2018Q4 | us-gaap |
Restricted Cash Noncurrent
RestrictedCashNoncurrent
|
1299000 | |
| CY2019Q1 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
432000 | |
| CY2018Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
244000 | |
| CY2019Q1 | us-gaap |
Assets
Assets
|
749369000 | |
| CY2018Q4 | us-gaap |
Assets
Assets
|
773855000 | |
| CY2019Q1 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
27265000 | |
| CY2018Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
29459000 | |
| CY2019Q1 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
34811000 | |
| CY2018Q4 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
34456000 | |
| CY2019Q1 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
6065000 | |
| CY2018Q4 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
6776000 | |
| CY2019Q1 | us-gaap |
Liabilities
Liabilities
|
68141000 | |
| CY2018Q4 | us-gaap |
Liabilities
Liabilities
|
70691000 | |
| CY2019Q1 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
| CY2018Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
| CY2019Q1 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
||
| CY2018Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
||
| CY2019Q1 | us-gaap |
Common Stock Value
CommonStockValue
|
121000 | |
| CY2018Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
121000 | |
| CY2019Q1 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
922816000 | |
| CY2018Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
914265000 | |
| CY2019Q1 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-243114000 | |
| CY2018Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-211528000 | |
| CY2019Q1 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
1405000 | |
| CY2018Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
306000 | |
| CY2019Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
681228000 | |
| CY2018Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
703164000 | |
| CY2019Q1 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
749369000 | |
| CY2018Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
773855000 | |
| CY2019Q1 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
4825000 | |
| CY2019Q1 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
7867000 | |
| CY2018Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
| CY2019Q1 | us-gaap |
Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
|
684000 | |
| CY2018Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
10000000 | |
| CY2018Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-2597000 | |
| CY2019Q1 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | |
| CY2018Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | |
| CY2019Q1 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | |
| CY2018Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | |
| CY2019Q1 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
| CY2018Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
| CY2019Q1 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
200000000 | |
| CY2018Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
200000000 | |
| CY2019Q1 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
121527320 | |
| CY2018Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
121482671 | |
| CY2019Q1 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
121527320 | |
| CY2018Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
121482671 | |
| CY2019Q1 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
23403000 | |
| CY2019Q1 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
13058000 | |
| CY2018Q1 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
2597000 | |
| CY2019Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
36461000 | |
| CY2018Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
2597000 | |
| CY2019Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-36461000 | |
| CY2017Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-2000 | |
| CY2018Q1 | allo |
Stock Issued During Period Value Common Stock Issues
StockIssuedDuringPeriodValueCommonStockIssues
|
5000 | |
| CY2018Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-2594000 | |
| CY2019Q1 | us-gaap |
Profit Loss
ProfitLoss
|
-31586000 | |
| CY2018Q1 | us-gaap |
Profit Loss
ProfitLoss
|
-2597000 | |
| CY2019Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
7867000 | |
| CY2018Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
0 | |
| CY2019Q1 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
151000 | |
| CY2018Q1 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
0 | |
| CY2019Q1 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
544000 | |
| CY2018Q1 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
0 | |
| CY2019Q1 | us-gaap |
Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
|
1223000 | |
| CY2018Q1 | us-gaap |
Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
|
0 | |
| CY2019Q1 | us-gaap |
Lease And Rental Expense
LeaseAndRentalExpense
|
1275000 | |
| CY2018Q1 | us-gaap |
Lease And Rental Expense
LeaseAndRentalExpense
|
0 | |
| CY2019Q1 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
-50000 | |
| CY2018Q1 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
0 | |
| CY2019Q1 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
1892000 | |
| CY2018Q1 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-5000 | |
| CY2019Q1 | us-gaap |
Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
|
188000 | |
| CY2019Q1 | us-gaap |
Operating Lease Expense
OperatingLeaseExpense
|
1000000 | |
| CY2018Q1 | us-gaap |
Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
|
0 | |
| CY2019Q1 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-348000 | |
| CY2018Q1 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
0 | |
| CY2019Q1 | us-gaap |
Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
|
-4095000 | |
| CY2018Q1 | us-gaap |
Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
|
2597000 | |
| CY2019Q1 | us-gaap |
Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
|
-711000 | |
| CY2018Q1 | us-gaap |
Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
|
0 | |
| CY2019Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-30256000 | |
| CY2018Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
5000 | |
| CY2019Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
10423000 | |
| CY2018Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
0 | |
| CY2019Q1 | us-gaap |
Proceeds From Sale And Maturity Of Other Investments
ProceedsFromSaleAndMaturityOfOtherInvestments
|
95708000 | |
| CY2018Q1 | us-gaap |
Proceeds From Sale And Maturity Of Other Investments
ProceedsFromSaleAndMaturityOfOtherInvestments
|
0 | |
| CY2019Q1 | us-gaap |
Payments To Acquire Investments
PaymentsToAcquireInvestments
|
52397000 | |
| CY2018Q1 | us-gaap |
Payments To Acquire Investments
PaymentsToAcquireInvestments
|
0 | |
| CY2019Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
32888000 | |
| CY2018Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
0 | |
| CY2019Q1 | us-gaap |
Proceeds From Stock Plans
ProceedsFromStockPlans
|
684000 | |
| CY2018Q1 | us-gaap |
Proceeds From Stock Plans
ProceedsFromStockPlans
|
0 | |
| CY2019Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
684000 | |
| CY2018Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
0 | |
| CY2019Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
3316000 | |
| CY2018Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
5000 | |
| CY2018Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
93731000 | |
| CY2017Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
0 | |
| CY2019Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
97047000 | |
| CY2018Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
5000 | |
| CY2019Q1 | us-gaap |
Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
|
5134000 | |
| CY2018Q1 | us-gaap |
Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
|
0 | |
| CY2019Q1 | us-gaap |
Payments For Leasing Costs Commissions And Tenant Improvements
PaymentsForLeasingCostsCommissionsAndTenantImprovements
|
391000 | |
| CY2018Q1 | us-gaap |
Payments For Leasing Costs Commissions And Tenant Improvements
PaymentsForLeasingCostsCommissionsAndTenantImprovements
|
0 | |
| CY2019Q1 | us-gaap |
Nature Of Operations
NatureOfOperations
|
<div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;font-weight:bold;letter-spacing:0.15pt;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-weight:bold;letter-spacing:0.15pt;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">1.</font></p></td> <td valign="top"> <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;font-weight:bold;letter-spacing:0.15pt;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Description of Business</p></td></tr></table></div> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Allogene Therapeutics, Inc. (the Company or Allogene) was incorporated on November 30, 2017, in the State of Delaware and is headquartered in South San Francisco, California. Allogene is a clinical-stage immuno-oncology company pioneering the development and commercialization of genetically engineered allogeneic T cell therapies for the treatment of cancer. The Company is developing a pipeline of off-the-shelf T cell product candidates that are designed to target and kill cancer cells. </p> <p style="text-align:justify;margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Initial Public Offering<font style="font-weight:normal;font-style:normal;"> </font></p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In October 2018, the Company completed an initial public offering (IPO) of its common stock. In connection with its IPO, the Company issued and sold 20,700,000 shares of its common stock, which included 2,700,000 shares of its common stock issued pursuant to the over-allotment option granted to the underwriters, at a price to the public of $18.00 per share. As a result of the IPO, the Company received approximately $343.0 million in net proceeds, after deducting underwriting discounts and commissions of $26.1 million and offering expenses of approximately $3.2 million payable by the Company. At the closing of the IPO, all 11,743,987 shares of outstanding convertible preferred stock were automatically converted into 61,655,922 shares of common stock and our outstanding convertible promissory notes in $120.2 million principal amount were automatically converted into 7,856,176 shares of common stock. Following the IPO, there were no shares of convertible preferred stock or preferred stock outstanding.</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Need for Additional Capital </p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company has sustained operating losses and expects to continue to generate operating losses for the foreseeable future. The Company’s ultimate success depends on the outcome of its research and development activities. The Company had cash and cash equivalents and investments of $680.7 million as of March 31, 2019. Since inception through March 31, 2019, the Company has incurred cumulative net losses of $243.1 million. Management expects to incur additional losses in the future to fund its operations and conduct product research and development and recognizes the need to raise additional capital to fully implement its business plan. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company intends to raise additional capital through the issuance of equity securities, debt financings or other sources in order to further implement its business plan. However, if such financing is not available when needed and at adequate levels, the Company will need to reevaluate its operating plan and may be required to delay the development of its product candidates. The Company expects that its cash and cash equivalents and investments will be sufficient to fund its operations for a period of at least one year from the date the accompanying unaudited condensed financial statements are filed with the Securities and Exchange Commission (SEC). </p> <p style="text-align:justify;margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Forward Stock Split </p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On October 1, 2018, the Company filed an amendment to the Company’s amended and restated certificate of incorporation to effect a forward split of shares of the Company’s common stock on a 1-for-5.25 basis (the Forward Stock Split). In connection with the Forward Stock Split, the conversion ratio for the Company’s then-outstanding convertible preferred stock was proportionately adjusted such that the common stock issuable upon conversion of such preferred stock was increased in proportion to the Forward Stock Split. The par value of the common stock was not adjusted as a result of the Forward Stock Split. All references to common stock, options to purchase common stock, early exercised options, share data, per share data, convertible preferred stock (to the extent presented on an as-converted to common stock basis) and related information contained in these condensed financial statements have been retrospectively adjusted to reflect the effect of the Forward Stock Split for all periods presented.</p> | |
| CY2018Q4 | us-gaap |
Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
|
261966000 | |
| CY2018Q4 | allo |
Cash Equivalents And Short Term Investments
CashEquivalentsAndShortTermInvestments
|
714132000 | |
| CY2019Q1 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Use of Estimates </p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of expenses during the reporting period. Significant estimates and assumptions made in the accompanying financial statements include but are not limited to the fair value of common stock, the fair value of stock options, the fair value of convertible notes payable, income tax uncertainties, and certain accruals. The Company evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors and adjusts those estimates and assumptions when facts and circumstances dictate. Actual results could differ from those estimates.</p> | |
| CY2019Q1 | us-gaap |
Debt Securities Available For Sale Term
DebtSecuritiesAvailableForSaleTerm
|
P3Y | |
| CY2019Q1 | us-gaap |
Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
|
24000 | |
| CY2018Q4 | us-gaap |
Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
|
320000 | |
| CY2019Q1 | allo |
Prepaid Research And Development Expenses Current
PrepaidResearchAndDevelopmentExpensesCurrent
|
4183000 | |
| CY2018Q4 | allo |
Prepaid Research And Development Expenses Current
PrepaidResearchAndDevelopmentExpensesCurrent
|
2356000 | |
| CY2019Q1 | us-gaap |
Accrued Investment Income Receivable
AccruedInvestmentIncomeReceivable
|
3391000 | |
| CY2019Q1 | us-gaap |
Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
|
608942000 | |
| CY2018Q4 | us-gaap |
Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
|
714132000 | |
| CY2019Q1 | us-gaap |
Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
|
20962000 | |
| CY2019Q1 | us-gaap |
Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
|
373392000 | |
| CY2019Q1 | us-gaap |
Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
|
214588000 | |
| CY2019Q1 | allo |
Cash Equivalents And Short Term Investments
CashEquivalentsAndShortTermInvestments
|
608942000 | |
| CY2018Q4 | us-gaap |
Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
|
85214000 | |
| CY2018Q4 | us-gaap |
Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
|
366952000 | |
| CY2019Q1 | dei |
Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
|
2017-11-30 | |
| CY2018Q4 | us-gaap |
Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
|
343000000 | |
| CY2019Q1 | us-gaap |
Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
|
680700000 | |
| us-gaap |
Net Income Loss
NetIncomeLoss
|
-243100000 | ||
| CY2018Q4 | us-gaap |
Stockholders Equity Note Stock Split
StockholdersEquityNoteStockSplit
|
1-for-5.25 | |
| CY2018Q4 | us-gaap |
Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
|
0.1905 | |
| CY2019Q1 | us-gaap |
Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
|
607370000 | |
| CY2018Q4 | us-gaap |
Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
|
713709000 | |
| CY2019Q1 | us-gaap |
Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
|
1596000 | |
| CY2018Q4 | us-gaap |
Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
|
743000 | |
| CY2018Q4 | allo |
Operating Leases Number Of Lease Agreements
OperatingLeasesNumberOfLeaseAgreements
|
2 | |
| CY2018Q3 | us-gaap |
Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
|
P7Y | |
| CY2019Q1 | allo |
Area Of Operating Lease
AreaOfOperatingLease
|
118000 | |
| CY2018Q3 | allo |
Allowance For Tenant Improvements
AllowanceForTenantImprovements
|
5100000 | |
| CY2018Q3 | us-gaap |
Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
|
1000000 | |
| CY2018Q4 | allo |
Area Of New Office Building
AreaOfNewOfficeBuilding
|
14943 | |
| CY2018Q4 | us-gaap |
Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
|
P124M | |
| CY2018Q4 | us-gaap |
Operating Loss Carryforwards Expiration Date
OperatingLossCarryforwardsExpirationDate
|
2029-02-28 | |
| CY2018Q4 | us-gaap |
Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
|
P7Y | |
| CY2018Q4 | allo |
Allowance For Tenant Improvements
AllowanceForTenantImprovements
|
800000 | |
| CY2018Q4 | us-gaap |
Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
|
200000 | |
| CY2018Q4 | us-gaap |
Accrued Investment Income Receivable
AccruedInvestmentIncomeReceivable
|
3108000 | |
| CY2019Q1 | us-gaap |
Prepaid Insurance
PrepaidInsurance
|
1629000 | |
| CY2018Q4 | us-gaap |
Prepaid Insurance
PrepaidInsurance
|
2376000 | |
| CY2019Q1 | us-gaap |
Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
|
1284000 | |
| CY2018Q4 | us-gaap |
Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
|
758000 | |
| CY2019Q1 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
22018000 | |
| CY2018Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
9643000 | |
| CY2019Q1 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
1592000 | |
| CY2018Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
1048000 | |
| CY2019Q1 | allo |
Unvested Shares Liabilities Current
UnvestedSharesLiabilitiesCurrent
|
5300000 | |
| CY2018Q4 | allo |
Unvested Shares Liabilities Current
UnvestedSharesLiabilitiesCurrent
|
4590000 | |
| CY2019Q1 | allo |
Accrued Research And Development Expense Current
AccruedResearchAndDevelopmentExpenseCurrent
|
4872000 | |
| CY2018Q4 | allo |
Accrued Research And Development Expense Current
AccruedResearchAndDevelopmentExpenseCurrent
|
7808000 | |
| CY2019Q1 | allo |
Accrued Compensation And Related Benefits Current
AccruedCompensationAndRelatedBenefitsCurrent
|
2719000 | |
| CY2018Q4 | allo |
Accrued Compensation And Related Benefits Current
AccruedCompensationAndRelatedBenefitsCurrent
|
4111000 | |
| CY2019Q1 | us-gaap |
Other Liabilities Current
OtherLiabilitiesCurrent
|
1398000 | |
| CY2018Q4 | us-gaap |
Other Liabilities Current
OtherLiabilitiesCurrent
|
612000 | |
| CY2018Q3 | allo |
Area Of New Office Building
AreaOfNewOfficeBuilding
|
68000 | |
| CY2018Q3 | us-gaap |
Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
|
P127M | |
| CY2018Q3 | us-gaap |
Operating Loss Carryforwards Expiration Date
OperatingLossCarryforwardsExpirationDate
|
2029-02-28 | |
| CY2019Q1 | us-gaap |
Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
|
P15Y8M | |
| CY2019Q1 | allo |
Allowance For Tenant Improvements
AllowanceForTenantImprovements
|
2900000 | |
| CY2019Q1 | us-gaap |
Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
|
3000000 | |
| CY2019Q1 | allo |
Operating Leases Commencement Date
OperatingLeasesCommencementDate
|
2020-05-31 | |
| CY2019Q1 | us-gaap |
Lessee Operating Lease Option To Extend
LesseeOperatingLeaseOptionToExtend
|
Upon certain conditions, the Company has two ten-year options to extend the lease | |
| CY2019Q1 | allo |
Number Of Options To Extend Lease
NumberOfOptionsToExtendLease
|
2 | |
| CY2019Q1 | us-gaap |
Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
|
P10Y | |
| CY2019Q1 | allo |
Payment Of Lease Rental Per Month
PaymentOfLeaseRentalPerMonth
|
159150 | |
| CY2019Q1 | us-gaap |
Lessee Operating Lease Variable Lease Payment Terms And Conditions
LesseeOperatingLeaseVariableLeasePaymentTermsAndConditions
|
Subject to rent abatement for the second through nine months of the lease, the Company will be required to pay $159,150 per month for rent for the first twelve months of the lease term which will increase at a rate of 3% per year. | |
| CY2019Q1 | allo |
Lessor Leasing Arrangements Operating Leases Annual Percentage Increase In Rent
LessorLeasingArrangementsOperatingLeasesAnnualPercentageIncreaseInRent
|
0.03 | |
| CY2019Q1 | us-gaap |
Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
|
3168000 | |
| CY2019Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
|
5971000 | |
| CY2019Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
|
7792000 | |
| CY2019Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
|
7958000 | |
| CY2019Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
|
8213000 | |
| CY2019Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
|
63517000 | |
| CY2019Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
|
96619000 | |
| CY2019Q1 | us-gaap |
Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
|
19333000 | |
| CY2019Q1 | allo |
Allowance For Tenant Improvements
AllowanceForTenantImprovements
|
5942000 | |
| CY2019Q1 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
35113000 | |
| CY2019Q1 | us-gaap |
Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
|
1400000 | |
| CY2019Q1 | us-gaap |
Variable Lease Payment
VariableLeasePayment
|
300000 | |
| CY2019Q1 | us-gaap |
Short Term Lease Commitment Amount
ShortTermLeaseCommitmentAmount
|
700000 | |
| CY2019Q1 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
7867000 | |
| CY2019Q1 | us-gaap |
Deferred Compensation Share Based Arrangements Liability Current
DeferredCompensationShareBasedArrangementsLiabilityCurrent
|
5300000 | |
| CY2019Q1 | us-gaap |
Deferred Compensation Sharebased Arrangements Liability Classified Noncurrent
DeferredCompensationSharebasedArrangementsLiabilityClassifiedNoncurrent
|
6100000 | |
| CY2019Q1 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
33500685 | |
| CY2018Q1 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
0 |
